well either this is the most undervalued phase 3 biotech stock on the Asx (potentially anywhere) or I’m a mug for picking up more shares at these prices.
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA
Ann: Dimerix Confirms Phase 3 FSGS Study Design With EMA, page-37
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
51.0¢ |
Change
0.035(7.37%) |
Mkt cap ! $286.1M |
Open | High | Low | Value | Volume |
47.5¢ | 54.0¢ | 47.5¢ | $3.360M | 6.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43786 | 51.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 15478 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 28 | 0.540 |
2 | 2750 | 0.535 |
1 | 950 | 0.530 |
2 | 20940 | 0.520 |
4 | 31100 | 0.515 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 1534 | 2 |
0.495 | 43845 | 2 |
0.500 | 50000 | 1 |
0.505 | 39304 | 2 |
0.510 | 5946 | 1 |
Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |